Delivery Order SPE2DB24D1006-SPE2DB25FCETK
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $4,366.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle. Performance will be executed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $12,393.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL in quantities of 10 units, with an ultimate completion date of December 29, 2025. This non-set-aside contract was competitively awarded on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,994.02 and an ultimate completion date of July 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $5,362.26 to AmerisourceBergen Drug Corp for the supply of Atropine 8 mg/20 mL vials on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designations and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader relationship with the...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,266.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atropine 8 mg/20 ml vials. This non-set-aside contract, with an ultimate completion date of April 24, 2025, represents a single delivery order fulfillment under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,577.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atropine 0.4 mg/ml in vial format. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is set to be completed by August 8, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCETKDelivery Order
The Defense Logistics Agency awarded a $3,905.93 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Atropine 8 mg/20 mL vials. This firm fixed-price contract, with an ultimate completion date of June 10, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive $999.999 billion indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant contracts with federal agencies including the Defense Health Agency and U.S. Coast Guard. The atropine procurement supports the military medical supply chain with a critical pharmaceutical used across defense healthcare systems. As part of DLA's broader pharmaceutical distribution network, this delivery order exemplifies the agency's sourcing of essential medications to support military medical operations and readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/9/25 |